Three prominent medical leaders propose a six-step licensing pathway to govern autonomous clinical AI, drawing direct parallels to physician licensing.
Key Details
- 1Current FDA frameworks are inadequate for regulating autonomous clinical AI, which evolves and acts dynamically.
- 2Authors propose standardized competency testing of clinical AI, modeled after US medical licensing exams and specialty boards.
- 3AI would require supervised deployment akin to medical residency, with performance monitoring before full approval.
- 4Certification would be time-limited and dependent on ongoing demonstration of clinical competence.
- 5AI developers and deploying institutions would have explicit, stratified accountability for safe implementation.
- 6Federal preemption is recommended to unify certification requirements and avoid fragmented state-based regulations.
Why It Matters
As AI systems increasingly perform clinician-like tasks, establishing rigorous, physician-style regulatory pathways could ensure safety, adaptability, and accountability. This approach may influence future policy and affect how imaging AI tools are certified and trusted in clinical practice.
Source
HealthExec
Related News
•AuntMinnie
ONC Official at SIIM Calls for Smarter AI and Better Image Sharing
ONC's Dr. Jason Funderburk urges improvements in medical image sharing and AI readiness at SIIM 2024.
•HealthExec
House Moves to Block AI-Driven Medicare Prior Authorization Pilot
A U.S. House committee voted to block the expansion of an AI-driven Medicare prior authorization pilot active in six states.
•Radiology Business
Navigating Payment and Reimbursement for Radiology AI Solutions
Radiology AI reimbursement in the US remains complex and fragmented, complicating provider and vendor payment strategies.